Skip to main content
Equibles

ALPS ADVISORS INC

Position in VCEL — Vericel Corp

CIK 1376113 Denver, CO
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,292,525
+$963,197 QoQ
Shares Held
51,529
+24.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#100
of 317 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. VCEL ranks #30 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2
62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in VCEL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,292,525 51,529
2026-03-31 $1,329,328 41,322
2025-12-31 $1,495,351 41,526
2025-09-30 $719,309 22,857
2025-06-30 $1,155,019 27,145
2025-03-31 $1,611,719 36,121
2024-12-31 $2,191,513 39,911
2024-09-30 $1,566,925 37,087
2024-06-30 $1,739,081 37,905
2024-03-31 $1,772,009 34,064
2023-12-31 $1,159,105 32,550
2023-09-30 $1,179,434 35,186
2023-06-30 $1,313,484 34,961
2023-03-31 $914,930 31,205
2022-12-31 $843,143 32,010
2022-09-30 $597,701 25,763
2022-06-30 $703,906 27,955
2021-09-30 $2,789,017 57,152
2021-06-30 $3,189,690 60,756
2021-03-31 $4,618,593 83,143
2020-12-31 $2,525,675 81,790
2020-09-30 $1,069,199 57,701
2020-06-30 $847,718 61,340
2020-03-31 $745,099 81,254